Mirae Asset Global ETFs Holdings
BPMC

Mirae Asset Global ETFs Holdings’s Blueprint Medicines BPMC Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45,534
Closed -$4.03M – 3037
2025
Q1 		$4.03M Buy
45,534
+2,679
+6% +$261K 0.01% 827
2024
Q4 		$3.74M Buy
42,855
+612
+1% +$56.1K 0.01% 859
2024
Q3 		$3.91M Buy
42,243
+4,555
+12% +$452K 0.01% 843
2024
Q2 		$4.06M Buy
+37,688
New +$3.77M 0.01% 814

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BPMC Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 45,534 shares — an estimated $4.03M sold.

Mirae Asset Global ETFs Holdings first reported a position in BPMC in Q2 2024 and held it in 4 quarters. The position peaked at $4.06M in Q2 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 45,534 Blueprint Medicines shares in Q2 2025, an estimated $4.03M.
  • Mirae Asset Global ETFs Holdings first reported a position in Blueprint Medicines in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Blueprint Medicines position peaked at $4.06M in Q2 2024.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.